Tumor cells frequently exploit these inhibitory pathways to escape immune surveillance, among which the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) pathways are the most representative. This evidence concerns the gene CTLA4 and neoplasm.